FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 235 filers reported holding FATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $66,894 | +4.0% | 2,985 | +15.0% | 0.00% | 0.0% |
Q2 2022 | $64,304 | -3.8% | 2,595 | +50.4% | 0.00% | +50.0% |
Q1 2022 | $66,878 | +97.1% | 1,725 | +197.4% | 0.00% | +100.0% |
Q4 2021 | $33,936 | -12.6% | 580 | -11.5% | 0.00% | 0.0% |
Q3 2021 | $38,822 | +496.4% | 655 | +773.3% | 0.00% | – |
Q2 2021 | $6,509 | -88.4% | 75 | -94.6% | 0.00% | -100.0% |
Q3 2020 | $55,958 | +41.8% | 1,400 | +21.7% | 0.00% | 0.0% |
Q2 2020 | $39,457 | – | 1,150 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |